The NIH SPAN Coordinating Center
NIH SPAN 协调中心
基本信息
- 批准号:10339173
- 负责人:
- 金额:$ 65.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-08-01 至 2022-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We propose a novel, adaptive, secured system for parallel testing of promising interventions designed to improve outcome compared to reperfusion alone with thrombolysis, thrombectomy or both. The applicant PI and collaborators together have decades of experience using preclinical animal stroke models. Also, and perhaps uniquely, the applicant PI and collaborators have led clinical trial coordinating centers for large and small multi‐center and single center Phase 1, 2, and 3 clinical trials on behalf of the Federal Government and various industry partners. Thus, by combining decades of experience and expertise in animal modeling with clinical trial management this application affords NINDS an opportunity to significantly enhance the likelihood that SPAN will guide the selection of the best agent(s) to transition to future clinical trials likely to be conducted through StrokeNet. The applicant PI and collaborators are aware of, and have participated in, many reviews and symposia detailing the significant failures of previous preclinical stroke development. A plethora of putative neuroprotectants proceeded to clinical trial based on favorable preclinical assessment, only to fail in subsequent clinical trials of human stroke patients. The plethora of clinical failures has cost industry and governments hundreds of millions of dollars and wasted the time, talent, and effort of hundreds of investigators and coordinators. The recent successful development of thrombectomy for acute ischemic stroke generated considerable enthusiasm for re‐testing compounds in combination with thrombectomy. Thus, SPAN is intended to screen and select highly promising candidate treatments for possible study in StrokeNet. A success in SPAN will provide a significant impetus to renew efforts toward successful clinical deployment of novel, promising neuroprotectants. In the past 5 years, two significant developments raise new hope for neuroprotection: the appearance of compounds with multiple mechanisms of action, and the promulgation of new standards for the rigorous preclinical development of stroke treatment candidates. The SPAN effort affords the highly significant opportunity to find a promising candidate treatment, test it in StrokeNet, and then back‐validate the ideal preclinical testing paradigm that predicts success in clinical trials. This present application, if funded, will achieve significant improvement and advancement of preclinical development by implementing critical technical innovations. The state‐of‐the‐art technical solution offered by our collaborator, the Laboratory of Neuroimaging (LONI) is secure, robust, reliable, and ready to implement immediately because Drs. Lyden and Toga collaborated during RHAPSODY to provide sites a turn‐key solution for uploading images (www.LONI.usc.edu). We also propose the highly novel use of distributed, masked evaluation. This novel approach allows for a secure, blinded, cost efficient, with built in central quality‐control.
我们提出了一种新型,自适应,有安全的系统,用于对旨在改善预后的承诺干预措施并行测试,与仅通过溶栓,血栓切除术或两者兼而有之。适用的PI和合作者共同使用临床前动物中风模型拥有数十年的经验。此外,也许是独特的,适用的PI和合作者领导了代表联邦政府和各个行业合作伙伴的大型和小型中心和单个中心1、2和3临床试验的临床试验协调中心。通过将数十年的动物建模经验和专业知识与临床试验管理结合起来,该应用程序可以显着增强SPAN的可能性,以指导最佳药物的选择,以过渡到可能通过Stromentet进行的未来临床试验。 PI和合作者的应用程序意识到并参与了许多评论和座谈会,详细介绍了先前的临床前中风开发的重大失败。基于有利的临床前评估,大量推定的神经保护剂进行了临床试验,但在随后的人类中风患者的临床试验中失败。众多的临床失败具有成本行业和政府数亿美元的成本,浪费了数百名调查人员和协调员的时间,才华和精力。急性缺血性中风的血栓切除术的最新成功开发产生了重新测试化合物与血栓切除术结合的考虑因素。跨度旨在筛选并选择高度有希望的候选治疗方法,以便在Strokenet中进行研究。成功的跨度将为成功的临床部署提供新的,有希望的神经保护剂的临床部署。在过去的5年中,两个重大的发展引起了神经保护的新希望:具有多种作用机理的化合物的出现,以及颁布新标准的新标准,以严格的临床前培养候选者。 SPAN的努力为找到有前途的候选治疗,在Strokenet中进行测试,然后进行后测量的理想临床前测试范式,以预测临床试验中的成功。本应用程序(如果资助)将通过实施关键的技术创新来实现临床前开发的重大改进和进步。我们的合作者神经影像学实验室(LONI)提供的最先进的技术解决方案是安全,健壮,可靠的,并且由于DRS而准备立即实施。 Lyden和Toga在Rhapsody期间合作,为站点提供了用于上传图像的交钥匙解决方案(www.loni.usc.edu)。我们还提出了对分布式,掩盖评估的高度新颖使用。这种新颖的方法允许使用中央质量控制的安全,盲目,具有成本效益。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Patrick D Lyden的其他基金
The NIH SPAN Coordinating Center
NIH SPAN 协调中心
- 批准号:1059175110591751
- 财政年份:2023
- 资助金额:$ 65.58万$ 65.58万
- 项目类别:
ZZ-3K3A-301: A multicenter, randomized, placebo-controlled, double-blinded, Phase 3 study to evaluate the efficacy and safety of 3K3A-APC (RHAPSODY-2)
ZZ-3K3A-301:一项多中心、随机、安慰剂对照、双盲、3 期研究,旨在评估 3K3A-APC (RHAPSODY-2) 的有效性和安全性
- 批准号:1030552810305528
- 财政年份:2022
- 资助金额:$ 65.58万$ 65.58万
- 项目类别:
The NIH SPAN Coordinating Center
NIH SPAN 协调中心
- 批准号:1007491710074917
- 财政年份:2020
- 资助金额:$ 65.58万$ 65.58万
- 项目类别:
The NIH SPAN Coordinating Center
NIH SPAN 协调中心
- 批准号:1022435510224355
- 财政年份:2019
- 资助金额:$ 65.58万$ 65.58万
- 项目类别:
ZZ-3K3A-201: Safety evaluation of 3K3A-APC in ischemic stroke
ZZ-3K3A-201:3K3A-APC在缺血性中风中的安全性评价
- 批准号:90954779095477
- 财政年份:2014
- 资助金额:$ 65.58万$ 65.58万
- 项目类别:
ZZ-3K3A-201: Safety evaluation of 3K3A-APC in ischemic stroke
ZZ-3K3A-201:3K3A-APC在缺血性中风中的安全性评价
- 批准号:87602768760276
- 财政年份:2014
- 资助金额:$ 65.58万$ 65.58万
- 项目类别:
ZZ-3K3A-201: Safety evaluation of 3K3A-APC in ischemic stroke
ZZ-3K3A-201:3K3A-APC在缺血性中风中的安全性评价
- 批准号:88803028880302
- 财政年份:2014
- 资助金额:$ 65.58万$ 65.58万
- 项目类别:
Thrombin mediated cytotoxicity during cerebral ischemia
脑缺血期间凝血酶介导的细胞毒性
- 批准号:1032759910327599
- 财政年份:2011
- 资助金额:$ 65.58万$ 65.58万
- 项目类别:
Thrombin mediated cytotoxicity during cerebral ischemia
脑缺血期间凝血酶介导的细胞毒性
- 批准号:99276789927678
- 财政年份:2011
- 资助金额:$ 65.58万$ 65.58万
- 项目类别:
Thrombin Mediated Cytotoxicity during Cerebral Ischemia
脑缺血期间凝血酶介导的细胞毒性
- 批准号:84486498448649
- 财政年份:2011
- 资助金额:$ 65.58万$ 65.58万
- 项目类别:
相似国自然基金
大跨度封闭气膜储煤仓结构力学性能退化机理及主动控制方法研究
- 批准号:52308222
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
面向大跨度结构的高强多孔骨料内养护UHPC徐变性能与模型研究
- 批准号:52308231
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于可变惯容调谐质量阻尼器的大跨度桥梁多模态涡振半主动控制方法研究
- 批准号:52378147
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
面向中国古诗文的长时间跨度知识图谱构建与深层知识发现研究
- 批准号:62372060
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
大跨度气承式膜结构风致流固耦合响应机理与智能化抗风设计研究
- 批准号:52378144
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
The NIH SPAN Coordinating Center
NIH SPAN 协调中心
- 批准号:1059175110591751
- 财政年份:2023
- 资助金额:$ 65.58万$ 65.58万
- 项目类别:
The NIH SPAN Coordinating Center
NIH SPAN 协调中心
- 批准号:1007491710074917
- 财政年份:2020
- 资助金额:$ 65.58万$ 65.58万
- 项目类别:
DATA COORDINATING CENTER FOR THE STUDY OF PREGNANCY AND NEONATAL HEALTH (SPAN)
妊娠和新生儿健康研究数据协调中心 (SPAN)
- 批准号:1002108110021081
- 财政年份:2019
- 资助金额:$ 65.58万$ 65.58万
- 项目类别:
DATA COORDINATING CENTER FOR THE STUDY OF PREGNANCY AND NEONATAL HEALTH (SPAN)
妊娠和新生儿健康研究数据协调中心 (SPAN)
- 批准号:1027138610271386
- 财政年份:2019
- 资助金额:$ 65.58万$ 65.58万
- 项目类别:
The NIH SPAN Coordinating Center
NIH SPAN 协调中心
- 批准号:1022435510224355
- 财政年份:2019
- 资助金额:$ 65.58万$ 65.58万
- 项目类别: